Our findings that tirzepatide has the highest risk of nausea and diarrhea, dulaglutide and lixisenatide the lowest, and exenatide the highest vomiting risk with dulaglutide showing a lower risk, are consistent with a recent meta-analysis reporting higher diarrhea risk for tirzepatide (risk ratio 1.812.18) than semaglutide (1.661.80) versus placebo, as well as trial data showing elevated nausea with tirzepatide and higher vomiting with exenatides short-acting formulation (Karagiannis et al., 2024)
Factor: Factor ships ready-to-eat meals in bulk, which cost approximately $10-14 each
Many press outlets heralded this as a challenge to telemedicine firms using compounded GLP-1 medications, even though this actually represents an increase in cost
Furtado DM, Bjrnmalm S, Ayton AI, Bush K, Kempe F, Caruso
Si efectivamente aumentaran significativamente el GLP-1 endgeno (lo cual no est bien establecido), podran tericamente causar efectos gastrointestinales
Oral semaglutide (currently available as Rybelsus) is not as powerful a weight-loss agent as Ozempic or Wegovy